Cargando…

Cardiac Amyloidosis: A Rare TTR Mutation Found in an Asian Female

Background: Transthyretin cardiac amyloidosis (ATTR) is a life-threatening, debilitating disease caused by abnormal formation and deposit of transthyretin (TTR) protein in multiple tissues, including myocardial extracellular matrix. It can be challenging to diagnose due to the myriad of presenting s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mouksian, Kristina, Ammon, Jessica, Pullen, Drenda, Zhang, Qiuhua, Yedlapati, Neeraja, Jefferies, John Lynn
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9863331/ https://www.ncbi.nlm.nih.gov/pubmed/36661908 http://dx.doi.org/10.3390/jcdd10010013

Ejemplares similares

Clinical Presentation, Diagnosis and Treatment of TTR Amyloidosis
por: Kapoor, Mahima, et al.
Publicado: (2019)

Population diversity of the genetically determined TTR expression in human tissues and its implications in TTR amyloidosis
por: Iorio, Andrea, et al.
Publicado: (2017)

Non-invasive risk stratification of patients with TTR amyloidosis
por: Scherer, Katrin A, et al.
Publicado: (2013)

The phenotypical expression of an European inherited TTR amyloidosis in Brazil
por: Cruz, Márcia Waddington, et al.
Publicado: (2015)

TTR amyloidosis: a scientific journey since Andrade
por: Saraiva, Maria João
Publicado: (2015)

Therapeutic Oligonucleotides Targeting Liver Disease: TTR Amyloidosis
por: Niemietz, Christoph, et al.
Publicado: (2015)

Diagnosis and treatment of gastrointestinal dysfunction in hereditary TTR amyloidosis
por: Obici, Laura, et al.
Publicado: (2019)

Neuropathology of central nervous system involvement in TTR amyloidosis
por: Taipa, Ricardo, et al.
Publicado: (2022)

TTR Amyloidosis: Current State of Affairs and Promise for the Future
por: Brailovsky, Yevgeniy, et al.
Publicado: (2023)

SOM0226, a repositioned compound for the treatment of TTR amyloidosis
por: Reig, Núria, et al.
Publicado: (2015)

Symptomatic therapy in ATTR amyloidosis: pain killers in TTR-FAP
por: Attal, Nadine
Publicado: (2015)

Diagnosis and treatment of urinary and sexual dysfunction in hereditary TTR amyloidosis
por: Bentellis, Imad, et al.
Publicado: (2019)

Prognostic value of soluble ST2 in AL and TTR cardiac amyloidosis: a multicenter study
por: Nicol, Martin, et al.
Publicado: (2023)

Four-Chamber Intracardiac Thrombi Complicating Wild-Type TTR Amyloidosis
por: Griffin, Jan M., et al.
Publicado: (2018)

TTR Gly83Arg Mutation: Beyond Familial Vitreous Amyloidosis
por: Li, Zhenxian, et al.
Publicado: (2022)

Case Report: A rare homozygous patient affected by TTR systemic amyloidosis with a prominent heart involvement
por: Micaglio, Emanuele, et al.
Publicado: (2023)

Summation of Precordial R Wave Amplitudes, a Clinical Parameter for Detecting Early TTR Amyloidosis Cardiac Involvement
por: Isotani, Yoshitaka, et al.
Publicado: (2022)

Neuropathologic analysis of Tyr69His TTR variant meningovascular amyloidosis with dementia
por: Ziskin, Jennifer L., et al.
Publicado: (2015)

Amyloidosis due to TTR mutations in Mexico with 4 distincts genotypes in the index cases
por: González-Duarte, Alejandra, et al.
Publicado: (2018)

The Transthyretin/Oleuropein Aglycone Complex: A New Tool against TTR Amyloidosis
por: Bemporad, Francesco, et al.
Publicado: (2022)

Uptake of Aggregating Transthyretin by Fat Body in a Drosophila Model for TTR-Associated Amyloidosis
por: Pokrzywa, Malgorzata, et al.
Publicado: (2010)

MALDI spectrometry for salivary samples analysis : a new tool for TTR amyloidosis diagnosis
por: Seguier, Julie, et al.
Publicado: (2015)

Autosomal-dominant transthyretin (TTR)-related amyloidosis is not a frequent CMT2 neuropathy “in disguise”
por: Grandis, Marina, et al.
Publicado: (2018)

Fatal TTR amyloidosis with neuropathy from domino liver p.Val71Ala transplant
por: Puffer, Ross C., et al.
Publicado: (2019)

Structural Stabilization of Human Transthyretin by Centella asiatica (L.) Urban Extract: Implications for TTR Amyloidosis
por: Eze, Fredrick Nwude, et al.
Publicado: (2019)

Wild-type TTR amyloidosis among patients with unexplained heart failure and systolic LV dysfunction
por: Goland, Sorel, et al.
Publicado: (2021)

The Expression of Chemokines Is Downregulated in a Pre-Clinical Model of TTR V30M Amyloidosis
por: Moreira, João, et al.
Publicado: (2021)

Motor Conduction Studies and Handgrip in Hereditary TTR Amyloidosis: Simple Tools to Evaluate the Upper Limbs
por: Di Stefano, Vincenzo, et al.
Publicado: (2022)

The Roles of Coronary Computed Tomography Angiography in Characterizing Coronary Plaque: Screening, Treatment, and Prevention
por: Pour-Ghaz, Issa, et al.
Publicado: (2023)

Treatment of transthyretin (TTR) amyloid cardiomyopathy with an antisense oligonucleotide inhibitor of TTR synthesis
por: Benson, Merrill D, et al.
Publicado: (2015)

Vitreous Amyloidosis as the Presenting Symptom of Familial Amyloid Polyneuropathy TTR Val30Met in a Portuguese Patient
por: Seca, Mariana, et al.
Publicado: (2014)

Case Report: Vitreous Amyloidosis Caused by a TTR Lys55Asn Mutation With Intraoperative Suprachoroidal Hemorrhage
por: Xu, Qing, et al.
Publicado: (2022)

Clinical improvement after change of therapy from tafamidis to patisiran in progressive TTR amyloidosis post-liver transplantation
por: Bulinski, Catherine, et al.
Publicado: (2022)

Teachings from the French database of TTR familial amyloidotic polyneuropathy (TTR-FAP): large genetic and phenotypic heterogeneity, usefulness of TTR gene testing.
por: Adams, David, et al.
Publicado: (2015)

Novel Device Therapies for Heart Failure
por: Alkhatib, Deya, et al.
Publicado: (2023)

Responder analysis for neuropathic impairment and quality-of-life assessment in patients with hereditary transthyretin amyloidosis with polyneuropathy in the NEURO-TTR study
por: Yarlas, Aaron, et al.
Publicado: (2021)

Comparison of MIBG and Diphosphonate scintigraphy in cardiac involvement of aTTR-FAP
por: Chequer, Renata, et al.
Publicado: (2015)

Hypertrophic Cardiomyopathy
por: Butt, Asra K., et al.
Publicado: (2023)

Epigallocatechin-3-Gallate as a Potential Therapeutic Drug for TTR-Related Amyloidosis: “In Vivo” Evidence from FAP Mice Models
por: Ferreira, Nelson, et al.
Publicado: (2012)

Long-term efficacy and safety of inotersen for hereditary transthyretin amyloidosis: NEURO-TTR open-label extension 3-year update
por: Brannagan, Thomas H., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_75l9mvrijdtd9dqijk21isl0rn